GHC vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GHC presents a contradictory profile: it is fundamentally stable but operationally stagnating. The Piotroski F-Score of 4/9 indicates stable health, and the stock trades below its Graham Number ($1282.03), suggesting defensive value. However, this is severely offset by a catastrophic -80.10% YoY earnings collapse and stagnant revenue growth (0.40%), indicating a significant deterioration in profitability. While the balance sheet is exceptionally clean with low debt, the bearish technical trend and high PEG ratio suggest the stock is currently a value trap.
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.
Compare Another Pair
Related Comparisons
GHC vs PG: Head-to-Head Comparison
This page compares Graham Holdings Company (GHC) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.